We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
-6.27%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$16.8B
AUM Growth
+$3.24B
(+24%)
Cap. Flow
+$4.87B
Cap. Flow
% of AUM
28.99%
Top 10 Holdings %
Top 10 Hldgs %
10.37%
Holding
3,295
New
862
Increased
762
Reduced
768
Closed
837
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$169M |
| 2 |
Coca-Cola
KO
|
+$155M |
| 3 |
McDonald's
MCD
|
+$140M |
| 4 |
Mondelez International
MDLZ
|
+$127M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$174M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$133M |
| 3 |
Workday
WDAY
|
+$110M |
| 4 |
Johnson & Johnson
JNJ
|
+$98.4M |
| 5 |
ConocoPhillips
COP
|
+$93.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Financials | 11.8% |
| 3 | Healthcare | 10.7% |
| 4 | Industrials | 9.22% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Protagonist Therapeutics
PTGX
$8.8B
| $769K | ﹤0.01% |
+91,276
| New | +$864K |
|
1302
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.23B
| $767K | ﹤0.01% |
+6,216
| New | +$840K |
|
1303
Fulgent Genetics
FLGT
$558M
| $765K | ﹤0.01% |
20,066
+2,772
| +16% | +$139K |
|
1304
National Health Investors
NHI
$3.81B
| $765K | ﹤0.01% |
+13,539
| New | +$853K |
|
1305
Dow Inc
DOW
$20.8B
| $764K | ﹤0.01% |
17,392
-1,089,513
| -98% | -$55.2M |
|
1306
iShares Russell Mid-Cap Growth ETF
IWP
$19.6B
| $764K | ﹤0.01% |
9,742
-44,877
| -82% | -$3.86M |
|
1307
Veru
VERU
$35.8M
| $764K | ﹤0.01% |
6,628
+92
| +1% | +$13.3K |
|
1308
Arthur J. Gallagher & Co
AJG
$68.2B
| $754K | ﹤0.01% |
+4,406
| New | +$782K |
|
1309
iShares Russell 1000 Growth ETF
IWF
$119B
| $754K | ﹤0.01% |
14,336
-38,256
| -73% | -$2.25M |
|
1310
Employers Holdings
EIG
$912M
| $749K | ﹤0.01% |
+21,707
| New | +$852K |
|
1311
iShares Latin America 40 ETF
ILF
$3.79B
| $749K | ﹤0.01% |
31,584
-103,249
| -77% | -$2.46M |
|
1312
iShares ESG Aware MSCI USA ETF
ESGU
$17.8B
| $748K | ﹤0.01% |
+9,418
| New | +$834K |
|
|
ARNC
1313
DELISTED
Arconic Corporation
ARNC
| $746K | ﹤0.01% |
+43,805
| New | +$1.14M |
|
|
KW
1314
DELISTED
Kennedy-Wilson Holdings
KW
| $743K | ﹤0.01% |
48,053
-10,773
| -18% | -$201K |
|
1315
Magnachip Semiconductor
MX
$118M
| $742K | ﹤0.01% |
72,420
+10,114
| +16% | +$133K |
|
1316
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.06B
| $736K | ﹤0.01% |
8,381
+1,964
| +31% | +$183K |
|
|
FOLD
1317
DELISTED
Amicus Therapeutics
FOLD
| $732K | ﹤0.01% |
+70,069
| New | +$781K |
|
1318
Bloom Energy
BE
$47.5B
| $730K | ﹤0.01% |
+36,530
| New | +$823K |
|
|
CGC
1319
Canopy Growth
CGC
$377M
| $729K | ﹤0.01% |
26,721
+11,186
| +72% | +$345K |
|
1320
Clean Energy Fuels
CLNE
$421M
| $728K | ﹤0.01% |
+136,325
| New | +$854K |
|
1321
Fidelity MSCI Energy Index ETF
FENY
$1.94B
| $724K | ﹤0.01% |
36,469
-4,105
| -10% | -$85.2K |
|
|
SPNS
1322
DELISTED
Sapiens International
SPNS
| $724K | ﹤0.01% |
37,773
+7,159
| +23% | +$162K |
|
1323
Diodes
DIOD
$3.69B
| $723K | ﹤0.01% |
11,132
-18,160
| -62% | -$1.31M |
|
1324
iShares MSCI Europe Financials ETF
EUFN
$4.05B
| $721K | ﹤0.01% |
51,818
+40,280
| +349% | +$622K |
|
1325
TTEC Holdings
TTEC
$119M
| $721K | ﹤0.01% |
+16,280
| New | +$968K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2022 Portfolio in Review
As of Q3 2022, Qube Research & Technologies (QRT) held 3,295 positions worth $16.8B, up 24% from $13.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.87B of net new capital in Q3 2022, opening 862 new positions and adding to 762 existing holdings. Its largest new stake was Coca-Cola: 2,493,071 shares worth $140M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $174M trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2022 buy was Coca-Cola: 2,493,071 shares worth $140M.
- Qube Research & Technologies (QRT) added most to Visa in Q3 2022, an estimated $169M increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $174M.
- Qube Research & Technologies (QRT) fully exited Phillips 66 in Q3 2022, selling an estimated $86.2M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $16.8B portfolio in Q3 2022.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 837 in Q3 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $16.8B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.